Investing.com - Organon Co (NYSE: OGN) reported third quarter EPS of $0.87, $0.18 worse than the analyst estimate of $1.05. Revenue for the quarter came in at $1.52B versus the consensus estimate of $1.57B.
Organon Co's stock price closed at $14.67. It is down -31.86% in the last 3 months and down -43.32% in the last 12 months.
Organon Co saw 1 positive EPS revisions and 6 negative EPS revisions in the last 90 days. See Organon Co's stock price’s past reactions to earnings here.
According to InvestingPro, Organon Co's Financial Health score is "good performance".
Check out Organon Co's recent earnings performance, and Organon Co's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar